Cell and gene sponsors, license holders, manufacturers, registries, collection sites, processing laboratories, and treatment sites are invited to learn how FACT Consulting Audit & Assessment Solution increases the return on investment in site assessments via specific, high-value benefits.
As reported extensively, the current industry qualification and auditing approach for cell and gene therapies is unsustainable and may delay or prevent patient access. FACT Consulting Audit & Assessment Solution can rapidly assess both accredited and non-accredited sites’ ability to participate in a company’s network, perform assessments on behalf of industry, and reduce the duplicative audit burden on healthcare sites while increasing the quality of their services. It is a win-win-win solution that reduces the audit burden on industry and sites to allow them to serve more patients.
FACT Consulting hosted a webinar announcing our new offering, FACT Audit & Assessment Solution. In addition to the energetic interest and support for this new solution, several questions have been asked about the types of assessments that can be performed, the target audience (both manufacturers and cellular therapy programs), and ways the audit reports can be leveraged to create efficiencies and time savings that our industry desperately needs by making them available for purchase.